• Target PharmaSolutions, Bristol-Myers Squibb partner to advance IBD research

    One year ago - By Healio

    Target PharmaSolutions has announced a strategic partnership with Bristol-Myers Squibb to conduct a longitudinal observational study that will evaluate patients with inflammatory bowel disease, including adult and pediatric patients with ulcerative colitis, Crohn's disease and indeterminate colitis, according to a company press release.
    “TARGET-IBD continues to collect valuable real-world data which enhances our understanding of the natural history of inflammatory bowel disease and the impact of different treatment paradigms on patient populations over time,” Millie D. Long,
    Read more ...


  • Inflammatory Bowel Disease Associated with Prostate Cancer

    Inflammatory Bowel Disease Associated with Prostate Cancer

    One year ago - By Medindia Health

    Men with inflammatory bowel disease are four to five times at risk for prostate cancer, finds a new study.
    Read more ...